Lucira Health (NASDAQ:LHDXQ) Versus Navidea Biopharmaceuticals (NYSE:NAVB) Head to Head Review
Lucira Health (NASDAQ:LHDXQ) Versus Navidea Biopharmaceuticals (NYSE:NAVB) Head to Head Review
Lucira Health (NASDAQ:LHDXQ – Get Rating) and Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.
Lucira Health（纳斯达克股票代码：LHDXQ — 获取评级）和 Navidea Biopharmaceuticals（纽约证券交易所代码：NAVB — 获取评级）都是小型医疗公司，但哪只是优势股？我们将根据分析师建议的强度、机构所有权、股息、盈利能力、估值、风险和收益来比较这两家企业。
Earnings and Valuation
收益和估值
This table compares Lucira Health and Navidea Biopharmaceuticals' revenue, earnings per share (EPS) and valuation.
该表比较了Lucira Health和Navidea Biopharmaceuticals的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | 0.08 | -$64.83 million | ($3.58) | -0.05 |
| Navidea Biopharmaceuticals | $70,000.00 | 135.53 | -$15.18 million | ($0.56) | -0.52 |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| 露西拉健康 | 9306 万美元 | 0.08 | -6,483 万美元 | (3.58 美元) | -0.05 |
| Navidea 生物制药 | 70,000.00 美元 | 135.53 | -1,518 万美元 | (0.56 美元) | -0.52 |
Navidea Biopharmaceuticals has lower revenue, but higher earnings than Lucira Health. Navidea Biopharmaceuticals is trading at a lower price-to-earnings ratio than Lucira Health, indicating that it is currently the more affordable of the two stocks.
Navidea Biopharmaceuticals的收入较低，但收益高于Lucira Health。Navidea Biopharmaceuticals的交易市盈率低于Lucira Health，这表明它目前是这两只股票中更实惠的一只。
Insider & Institutional Ownership
内部所有权和机构所有权
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 5.6% of Navidea Biopharmaceuticals shares are held by institutional investors. 30.4% of Lucira Health shares are held by insiders. Comparatively, 45.2% of Navidea Biopharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Lucira Health的57.0％股票由机构投资者持有。相比之下，有5.6％的Navidea Biopharmaceuticals股票由机构投资者持有。30.4％的Lucira Health股票由内部人士持有。相比之下，Navidea Biopharmaceuticals的股票中有45.2％由内部人士持有。强大的机构所有权表明大型基金经理、捐赠基金和对冲基金认为股票有望实现长期增长。
Analyst Recommendations
分析师建议
This is a summary of current recommendations and price targets for Lucira Health and Navidea Biopharmaceuticals, as provided by MarketBeat.com.
这是Marketbeat.com提供的Lucira Health和Navidea Biopharmaceuticals当前的建议和目标价格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Navidea Biopharmaceuticals | 0 | 0 | 0 | 0 | N/A |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不适用 |
| Navidea 生物制药 | 0 | 0 | 0 | 0 | 不适用 |
Risk & Volatility
风险与波动性
Lucira Health has a beta of 3.36, suggesting that its share price is 236% more volatile than the S&P 500. Comparatively, Navidea Biopharmaceuticals has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500.
Lucira Health的beta值为3.36，这表明其股价的波动性比标准普尔500指数高236％。相比之下，Navidea Biopharmaceuticals的beta值为1.5，这表明其股价的波动性比标准普尔500指数高50％。
Profitability
盈利能力
This table compares Lucira Health and Navidea Biopharmaceuticals' net margins, return on equity and return on assets.
该表比较了Lucira Health和Navidea Biopharmaceuticals的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Navidea Biopharmaceuticals | N/A | N/A | -362.74% |
| 净利润 | 股本回报率 | 资产回报率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| Navidea 生物制药 | 不适用 | 不适用 | -362.74% |
Summary
摘要
Navidea Biopharmaceuticals beats Lucira Health on 6 of the 11 factors compared between the two stocks.
Navidea Biopharmaceuticals在两只股票比较的11个因素中有6个击败了Lucira Health。
About Lucira Health
关于 Lucira Health
(Get Rating)
（获取评分）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家医疗技术公司。它专注于变革性和传染病检测试剂盒的开发和商业化。Lucira Health Inc. 总部位于加利福尼亚州的埃默里维尔。
About Navidea Biopharmaceuticals
关于 Navidea Bioparmaceuticals
(Get Rating)
（获取评分）
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
Navidea Biopharmaceuticals, Inc. 从事精准免疫诊断药物和免疫疗法的开发和商业化。它通过以下部门运营：诊断、治疗和企业。该公司成立于1983年，总部位于俄亥俄州都柏林。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Lucira Health及相关公司的最新新闻和分析师评级的简明每日摘要。